A Look Back at Immunomedics' Volatile but Rewarding 2013

Filed under: Seattle Drug Treatment

This was a solid year for Immunomedics , a company focused on the development of monoclonal antibodies for the targeted treatment of cancer, autoimmune disorders, and other diseases. Shares have climbed more than 50% since the … Immunomedics …
Read more on DailyFinance

Minorities, women struggle with unequal access to cancer care

Filed under: Seattle Drug Treatment

ATLANTA — Advancements in cancer research have enabled better detection and treatment of cancers and even better quality of life for cancer survivors, but is a significant portion of the U.S. public getting left behind? Even as the Affordable Care Act …
Read more on Al Jazeera America

Novartis, Gilead, Genentech & More: An ASH 2013 Wrap-Up

Filed under: Seattle Drug Treatment

… patients who got the experimental treatment. Marchione's piece didn't mention the big new kid on the CART block—Seattle-based Juno Therapeutics, which raised a $ 120 million Series A venture financing last week. … Gilead Sciences (NASDAQ: GILD …
Read more on Xconomy

Social Worker II

Filed under: Seattle Drug Treatment

The Seattle Cancer Care Alliance (SCCA), located in Seattle, Washington, is part of a dynamic collaboration among three organizations known nationally and internationally for their patient care and research: Fred Hutchinson Cancer Research Center …
Read more on Scientific American